Meet our Management Team

Tom Douthitt

PRESIDENT & CEO

Tom Douthitt has held key domestic and international management positions within large Fortune 500 companies as well as small start-up companies, and he helped lead his last two start-ups to successful acquisitions. He has nearly 30 years’ experience primarily in the fields of vascular intervention and structural heart.

Richard Van Bibber

VICE PRESIDENT, CLINICAL AFFAIRS

Dr. Van Bibber has 20 years of medical device product development and clinical training experience working in pre-clinical, incubator, start-up and commercial environments. He has played critical roles in multinational clinical trials serving as lead trainer and proctor for physicians using novel implantable cardiovascular devices.

Shannon Eubanks

Vice President, Engineering & Operations

Shannon Eubanks brings 20 years of engineering experience in both large and early stage medical device companies, and has been responsible for new product development, quality systems, and product manufacturing. Ms. Eubanks has led teams along the full spectrum of the product development cycle.

Our Board of Directors

Chad Robins

FOUNDING DIRECTOR

Mr. Robins is CEO & President, Adaptive Biotechnologies Corp. He has held executive level positions across multiple industries, including banking, real estate, investing and biotechnology. Mr. Robins also holds a board position for the American Heart Association (Puget Sound).

Benjamin W. Starnes, MD

MEDICAL FOUNDER

Dr. Starnes is the chief of vascular and endovascular surgery at the University of Washington (UW) and Harborview Medical Center. He is also a Professor of Surgery at UW and has been a board certified surgeon from the American Board of Surgery since 1998. He served in the United States Army for 15 years and is considered an international expert on the management of aortic disease.

Paul Buckman

President & CEO, Conventus Orthopaedics

Thirty-seven years of medical device experience in general management, sales, marketing, finance, international and operations. Paul was President of the Cardiovascular Divisions of Boston Scientific and St. Jude Medical. He was also co-founder, Chairman, and CEO of ev3 and had previous CEO roles with SentreHeart and Pathway Medical.

Our Scientific Advisory Board

Frank J. Veith, MD

PROFESSOR OF SURGERY, NEW YORK UNIVERSITY & THE VON LIEBIG CHAIR IN VACULAR SURGEY, CLEVELAND CLINIC

Dr. Veith is a leading vascular surgeon who has the distinction of his group performing the first ever EVAR surgery in the US. Dr. Veith also chairs the largest Vascular Surgery meeting, the VEITH symposium, held annually in New York.

Juan C. Parodi, MD

CHIEF OF VASCULAR SURGERY, TRINIDAD HOSPITAL, SAN ISIDRO, BUENOS AIRES

Dr. Parodi has been a leading vascular surgeon for decades and is well known for his development of the Parodi Endograft, the first endograft created to treat an aorta. He published his first results in 1991, and helped influence the vascular surgery field’s move towards less invasive approaches to vascular repair.

Stéphan Haulon, MD

CHIEF OF VASCULAR SURGERY, LILLE UNIVERSITY HOSPITAL, FRANCE

Dr. Haulon is the chief of the vascular medical and surgical center at Lille University Hospital, which is the largest facility of its kind in France and one of the largest in Europe. He is an internationally known expert in endovascular aortic repair, particularly in complex thoraco-abdominal (TAA) and arch aortic aneurysms and dissections.

Zachary M. Arthurs, MD

CHIEF OF VASCULAR SURGERY, SAN ANTONIO MILITARY MEDICAL CENTER, SAN ANTONIO, TX

Dr. Arthurs is a well-respected general and vascular surgeon at the busiest inpatient medical facility in the Department of Defense. He is skilled in endovascular techniques to treat vascular trauma as well as aortic aneurysms; and incorporates advanced imaging modalities in his practice.

Matthew Eagleton, MD

Vascular Surgery Director, The Aortic Center, Cleveland Clinic

Dr. Eagleton is a vascular surgeon in the Department of Vascular Surgery of the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. Dr. Eagleton’s specialty interests include endovascular and open surgery for complex aortic disease including aortic aneurysms and aortic dissection, aneurysm pathogenesis, pediatric and congenital vascular disease and vessel wall matrix remodeling.

Timothy Resch, MD

Chairman, Vascular Center Skåne University Hospital, Malmö, Sweden

Dr. Resch is Chairman at the Vascular Center in Malmö Sweden. He completed his fellowship in aortic surgery under the guidance of Roy Greenberg and continues research focused on endovascular aortic repair and advanced imaging techniques. He has been published numerous times in the field of vascular surgery and is an investigator in several endovascular aortic repair trials.